Drugmakers Are Set to Pay 23andMe Millions to Access Consumer DNA::GSK will pay the DNA testing company $20 million for non-exclusive access to genetic data.

  • Ghostalmedia@lemmy.world
    link
    fedilink
    English
    arrow-up
    6
    ·
    11 months ago

    True, but I think the shady thing is that the data transmission is framed as “Research Participation” - which sounds a lot better than “allow us to sell your data to other companies and institutions.”